Therapeutic cannabinoids in multiple sclerosis: immunomodulation revisited
Cannabinoids are compounds with pleiotropic properties that act on the cannabinoid receptors, CB1 and CB2, and are divided into endocannabinoids, the endogenous ligands of these receptors, synthetic cannabinoids and phytocannabinoids. The latter are derived from the plant Cannabis sativa. The therap...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018
|
| Online Access: | http://eprints.nottingham.ac.uk/51035/ http://eprints.nottingham.ac.uk/51035/ http://eprints.nottingham.ac.uk/51035/ http://eprints.nottingham.ac.uk/51035/1/editorial%20EJoN%20PG%20accepted.pdf |